Home » Topics » Regulatory

Regulatory
RSS

Low-dose Climara approved by FDA as starting dose for menopausal symptoms

April 23, 2001

Paxil approved for generalized anxiety disorder

April 18, 2001

FDA issues approvable letter for Celebrex revised labeling

April 18, 2001

Hemopure approved for the first time in South Africa

April 11, 2001

FDA issues approvable letter for changes to Vioxx labeling

April 11, 2001

Roche files for E.U. approval of Xeloda/Taxotere combination for treatment of breast cancer

April 11, 2001

Combination therapies for restless legs syndrome devised by Boehringer Ingelheim

April 10, 2001

Schering-Plough patents use of antiallergic agents for CNS, vascular disorders

April 10, 2001

Use of modafinil in anorexia

April 10, 2001

AstraZeneca beta-blocker now available in U.S. for heart failure treatment

April 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.